Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Zilretta™, Flexion’s non-opioid lead drug candidate (also known as FX006), completed pivotal Phase 2b ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email